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a b s t r a c t
To determine the hierarchy of transcriptional regulation within the in vivo vertebrate embryo, we
examined whether developmental enhancers were inﬂuenced by Nodal signaling during early embry-
ogenesis in Xenopus tropicalis. We ﬁnd that developmental enhancers, deﬁned by the active enhancer
chromatin marks H3K4me1 and H3K27ac, are established as early as blastula stage and that Smad2/3
only strongly associates with these regions at gastrula stages. Signiﬁcantly, when we perturb Nodal
signaling using the drug SB431542, most enhancers remain marked, including at genes known to be
sensitive to Nodal signaling. Overall, as enhancers are in an active conformation prior to Nodal signaling
and are established independently of Nodal signaling, we suggest that many developmental enhancers
are marked maternally, prior to exposure to extrinsic signals.
& 2014 Published by Elsevier Inc.
Introduction
Enhancers are distinct genomic regions that control temporal
and spatial transcription. Hundreds of thousands of enhancers are
scattered throughout the genome of all organisms, but only a
fraction of these are utilized at any given time or any given cell. As
enhancer usage is complex – varying in both developmental stages
and cell types – elucidating these regions in vivo has been difﬁcult.
Many cell type speciﬁc enhancers, particularly in model organ-
isms, have been identiﬁed and characterized using promoter
bashing, gel shift assays and ﬁngerprinting methodologies. Only
recently have enhancers been identiﬁed on a genome-wide scale
using chromatin immunoprecipitation followed by sequencing
(ChIP-Seq) (Andersson et al., 2014; Bonn et al., 2012; Heintzman
et al., 2009). Collectively, this work has shown that enhancers
are regions of the genome that are depleted for nucleosomes.
Further, the nucleosomes that exist on either side of the open
chromatin contain speciﬁc histone modiﬁcations which are highly
correlated with either active, repressed or poised neighboring
gene transcription (Creyghton et al., 2010; Rada-Iglesias et al.,
2011). Therefore, examining these open chromatin regions and
their associated histone variants can strongly predict how a
regulatory region is being utilized. H3K4me1, when bound either
alone or together with H3K27me3, is not associated with tran-
scription of neighboring genes and therefore enhancers containing
these signatures are considered primed or poised (Shlyueva et al.,
2014). If, however, H3K4me1 is bound together with H3K27ac
then this combination is strongly associated with neighboring
gene transcription and these regions are considered active enhan-
cers (Creyghton et al., 2010; Rada-Iglesias et al., 2011; Shlyueva
et al., 2014). The presence of a speciﬁc transcription factor at such
regions provides additional support for the enhancer being active
(Kim et al., 2011). Overall, genomic regions that contain H3K4me1,
H3K27ac and a transcription factor are highly likely to be function-
ing as active enhancers within that cellular context.
In the vertebrate embryo, it is unknown when enhancer marks
are established during gestation, and whether their establishment
is primarily dependent on maternal or zygotic proteins. Under-
standing how developmental enhancers are established and
whether they are guided by speciﬁc transcription factors is the
key to mechanistically understanding the hierarchy of transcrip-
tional networks during embryogenesis. There is ample precedence
from work in Drosophila showing that enhancer marks precede
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transcription factor binding (Bonn et al., 2012; Negre et al., 2011),
although some transcription factors, termed pioneers, are known
to unwind chromatin and recruit histone variants (Zaret and
Carroll, 2011). In the Xenopus embryo, the maternally supplied
pioneer factor FoxH1/Fast1 is known to be critical for proper germ
layer speciﬁcation and patterning of the early embryo, suggesting
that maternal factors can act in the establishment of early gene
transcription (Kofron et al., 2004; Watanabe and Whitman, 1999).
However, while some activities of maternal FoxH1 are Smad-
independent, a primary activity of FoxH1 is to activate gene
transcription by binding activin response elements together with
Smads, which are not active in the nucleus until after zygotic
transcription begins (Chen et al., 1996, 1997). The timing of FoxH1
binding, enhancer mark deposition, and Smad binding at enhan-
cers is unknown. There is also evidence that chromatin marks
are remodeled prior to zygotic transcription, as the promoter
mark H3K4me3 is established at some key early developmental
genes through the action of β-catenin and the arginine methyl-
transferase Prmt2 (Blythe et al., 2010). However, the global
hierarchy of transcription factor binding events and chromatin
mark establishment is unclear: it remains unknown whether the
transcription factor recruits enhancer chromatin marks or whether
these chromatin marks permit transcription factor binding.
With the sequencing of Xenopus tropicalis, this organism has
become amenable to examine the hierarchy of events that under-
lies the formation of the vertebrate body plan at the level of
enhancers. In this report, we examine the sequence of deposition
of the enhancer marks H3K4me1 and H3K27ac, and of the Nodal
transcription factor, Smad2/3, immediately following zygotic tran-
scription and continuing through gastrulation. We ﬁnd that
regions marked by H3K4me1 and H3K27ac are associated with
key developmental genes at the onset of zygotic transcription.
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Fig. 1. Occupancy of H3K4me3 and H3K27me3 in X. tropicalis at stage 8, 9 and 10.5. (A) Table showing the breakdown of numbers from the ChIP-Seq datasets for H3K4me3
(top) and H3K27me3 (bottom), including the number of regions identiﬁed and the genes that could be associated to the regions. Each category is depicted for stages 8, 9 and
10.5. (B) Histograms showing where the regions bound by either H3K4me3 (top) or H3K27me3 (bottom) exist with respect to annotated TSS regions at stage 10.5. The
number of bound regions is plotted on the Y axis, with the distance from nearest TSS along the X axis. (C) Venn diagram showing how the regions bound to H3K4me3
compare between stage 8, 9 and 10.5. (D) Venn diagram showing how the genes associated with H3K4me3 compare between stage 8, 9 and 10.5. (E) DAVID analysis for genes
associated with H3K4me3 at stage 8, 9 and 10.5 (red, yellow and green, respectively).
R. Gupta et al. / Developmental Biology 395 (2014) 38–49 39
However, these regions are not generally associated with either
the transcription factor Smad2/3 or with active promoters until
gastrulation. Further, using perturbations within the Xenopus
embryo, we ﬁnd that the presence of H3K4me1 and H3K27ac at
these regions is independent of functional Nodal signaling. Overall,
we suggest that, in X. tropicalis, many important developmental
enhancers are marked at or prior to zygotic transcription, but are
not dependent on zygotic signaling, particularly Nodal, for their
establishment.
Results and discussion
Promoter identiﬁcation at blastula and gastrula stages using
H3K4me3 and H3K27me3 in X. tropicalis
In order to deﬁne promoter elements in X. tropicalis, we
examined the occupancy of H3K4me3 and H3K27me3 using
ChIP-Seq. Promoters are nucleosome depleted regions of the
chromatin. If H3K4me3 is present on the nucleosomes ﬂanking
these open chromatin regions there is a strong correlation with
active transcription (Rada-Iglesias et al., 2011; Shlyueva et al.,
2014). Conversely, if H3K27me3 is present, there is a correlation
with absence of transcription (reviewed in Shlyueva et al., 2014).
Therefore, these two epigenetic marks are useful in characterizing
active vs silent promoters within the genome. Our analysis focused
on the early stages of embryonic differentiation, including mid-
blastula embryos near the onset of zygotic transcription (stage 8,
Nieuwkoop and Faber staging criteria) (Nieuwkoop and Faber,
1967), late blastula embryos undergoing germ layer speciﬁcation
(stage 9), and early gastrula embryos undergoing dorsal–ventral
patterning and gastrulation morphogenesis (stage 10.5). For each
stage and histone mark, 10 to 59 million reads were aligned to
version xenTro2 using MACS2.08 at a stringent q value of 0.0001
(see the Experimental procedures section).
For the active promoter mark, H3K4me3, we identiﬁed
2,010, 6,839 and 14,549 peaks at stages 8, 9 and 10.5, respectively
(Fig. 1A). At each stage these regions are predominantly located
either within 1 kb of a transcription start site (TSS) or within
intergenic regions greater than 30 kb from a TSS (Fig. 1B). Further,
when we compare all regions that contain a H3K4me3 mark
between all embryonic stages, we ﬁnd signiﬁcant overlap, with
most of the marks present at stage 8 and 9 being represented at
stage 10.5 (Fig. 1C).
Next we identiﬁed the genes that are associated with a H3K4me3
marked region within 1 kb of a transcription start site (TSS) using
HOMER software (Heinz et al., 2010) (see the Experimental proce-
dures section). We ﬁnd 683, 3266, and 4739 genes at stages 8, 9 and
10.5, respectively. We next compared the overlap of these genes
between each stage (Fig. 1D). The majority of genes with a promoter
containing H3K4me3 at stage 8 remain marked at both stage 9 and
stage 10.5, and most promoters that acquire a mark at stage 9 retain
it at stage 10.5 (2757/3266). There is a gradual accumulation of
blastula- or gastrula-speciﬁc active promoters that are used as
development proceeds (353/3266 at stage 9 and 1952/4739 at stage
10.5). Overall, H3K4me3 bound promoters at stage 8 and stage
9 strongly predict the continued presence of this mark at stage
10.5—suggesting that active promoters remain stable as early devel-
opment progresses.
We then examined the function of the genes associated with
active promoters at all stages using the gene ontology analysis tool
DAVID (Huang et al., 2009a, 2009b). We ﬁnd signiﬁcant enrichment
for the terms “Ribonuclear protein complex” (stage 8, p¼6.210–11;
stage 9, p¼1.010–12; stage 10.5, p¼4.410–12) and “RNA recogni-
tion motif” (stage 8, p¼3.3106; stage 9, 1.6106; stage 10.5,
0.022) (Fig. 1E) (Supplemental Table S1), likely reﬂecting functions
involved in initiating zygotic transcription. The functional categories
also include terms associated with housekeeping functions like
“Protein catabolic process” (stage 9; p¼1.5104; stage 10;
p¼1.3107), “ATP binding” (stage 9, p¼3.3104; stage 10.5,
p¼1.4105), “Intracellular non-membrane organelle” (stage 8,
p¼1.7104; stage 9, p¼4.71010), “Membrane enclosed lumen”
(stage 9, p¼1.6104; stage 10.5, p¼1.9106). Overall, this
suggests that most active promoters during early embryonic devel-
opment are strongly enriched for basic metabolic functions. We do
not see enrichment for terms associated with early embryonic
development. Certainly, some early developmental regulators are
marked by H3K4me3, but among the thousands of H3K4me3
promoters we identiﬁed, basic transcriptional and metabolic func-
tions predominate at all three stages.
We conducted a similar analysis at each of the three stages with
the repressive promoter mark, H3K27me3, and ﬁnd very few
instances of binding genome-wide, including only 75 regions at
stage 8 and 179 at stage 10.5 (Fig. 1A). Of the regions identiﬁed at
each time point, most are found within intergenic regions more than
30 kb from an annotated TSS (Fig. 1B). These results are consistent
with what has previously been described in X. tropicalis (Akkers et al.,
2009; van Heeringen et al., 2013), and support the notion that
Polycomb Complex activity is minimal during early embryonic
development in X. tropicalis (van Heeringen et al., 2013). Like other
researchers, we conclude that promoter poising through bivalent
H3K4me3/H3K27me3 marks is not a common mechanism for
regulating gene expression in the early Xenopus embryo.
Putative enhancers are associated with developmental genes at early
blastula stages
We next sought to elucidate enhancers during blastula and
gastrula stages genome wide in X. tropicalis. While it is thought that
enhancers are stable in adult organ systems, research in embryonic
stem cells and in invertebrate model organisms suggests that
enhancers are utilized transiently during development (Bonn et al.,
2012; Calo and Wysocka, 2013; Lindeman et al., 2011; Negre et al.,
2011; Rada-Iglesias et al., 2011; Rada-Iglesias and Wysocka, 2011).
Therefore, understanding enhancers and how they vary throughout
embryogenesis will provide both the means of targeting these
regions and an appreciation for how they are used within a temporal
context. To identify embryonic enhancers marked during blastula
and gastrula stages in X. tropicalis, we performed ChIP-Seq for
H3K27ac and H3K4me1 (Bonn et al., 2012; Creyghton et al., 2010;
Shlyueva et al., 2014; Zentner et al., 2011). We ﬁnd thousands of
genomic regions containing each mark, increasing in number at each
subsequent developmental stage (see Fig. 2A).
As regions containing both H3K4me1 and H3K27ac have been
associated with active enhancers (Bonn et al., 2012; Creyghton
et al., 2010; Rada-Iglesias et al., 2011; Shlyueva et al., 2014), we
then identiﬁed regions genome-wide that contained overlapping
H3K27ac and H3K4me1 at each stage (Fig. 2B). We ﬁnd consider-
able overlap between the two marks at each stage genome-wide
(Fig. 2B). Interestingly, by stage 10.5, 90% of regions that are
marked by H3K27ac also contain H3K4me1. Given the body of
literature linking these two variants to enhancer function, we
designated regions marked by both H3K27ac and H3K4me1 as
putative enhancers. Throughout the remaining text, we will refer to
these as putative enhancers. Validation of known Nodal enhancer
elements (see Fig. 4) suggests that many of these are active
enhancers utilized during gastrulation in X. tropicalis.
We next examined whether putative enhancers change between
embryonic stages (Fig. 2D). We ﬁnd that, once marked, most of these
elements remain throughout subsequent stages (Fig. 2D, left Venn).
Of the 2736 putative enhancers identiﬁed at stage 8, 2019 (74%)
remain marked at both stage 9 and stage 10.5. Less than 10% are
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Fig. 2. Occupancy of H3K27ac and H3K4me1 in X. tropicalis at stages 8, 9 and 10.5. (A) Table showing the breakdown of numbers from the ChIP-Seq datasets from H3K4me1
(left) and H3K27ac (right), including the number of regions identiﬁed and the genes that could be associated to the regions. Each category is depicted for stages 8, 9 and 10.5.
(B) Venn diagrams showing overlap between regions bound by H3K27ac and H3K4me1 at stage 8, 9 and 10.5. (C) Venn diagrams showing overlap between the genes that can
be associated with a region bound by H3K27ac and/or H3K4me1. (D) Table summarizing the number of regions bound by both H3K4me1 and H3K27ac and the associated
genes at each stage. Venn diagrams depict the overlap of either the regions or associated genes. (E) DAVID analysis of genes associated to a region that is co-bound by
H3K27ac and H3K4me1 at all stages (see intersection in Venn diagrams from (D)). X axis is the –log10 of p value for each term.
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found exclusively at stage 8 and only 15.5% are speciﬁc to stage 9.
However, 62% of the putative enhancers are speciﬁc for stage 10.5,
supporting the idea that as development becomes more complex
there is a requirement for a greater repertoire of enhancers.
We next sought to identify genes associated with putative
enhancers (Fig. 2C). We ﬁnd 2180, 4719 and 6641 genes at stages
8, 9, 10.5, respectively (Fig. 2D). After comparing these stages, we ﬁnd
that 87% of genes associated with a putative enhancer at stage 8 stay
associated through stage 10.5. We then performed DAVID analysis
using the 1901 genes associated with a putative enhancer across all
stages and found ﬁve enriched categories including “Regulation of
transcription” (p¼1.11010), “Ribonuclear protein complex”
(p¼1.2108), “Zinc Finger” (p¼4.4105), “RNA recognition
motif” (p¼1.5104), and “Cyclin” (p¼3.8105) (Fig. 2E).
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Fig. 3. Identiﬁcation of putative Nodal enhancers in blastula and gastrula. (A) Identiﬁcation of regions bound by Smad2/3 and genes associated with these regions at stage 8,
9 and 10.5. The number of genes associated with Smad2/3 bound regions is further classiﬁed into those whose expression was detected by 3SEQ. (B) Venn diagrams
comparing regions bound by Smad2/3 at stages 9 and 10.5 (left) and the genes that are associated to Smad2/3 binding at stages 9 and 10.5 (right). (C) Box plot representation
of transcript abundance of genes associated with a Smad2/3 bound region (blue) and those that are not associated with a Smad2/3 bound region (green) at stage 9 (293
expressed genes associated with Smad2/3 binding vs. 6555 not associated) and stage 10.5 (404 genes vs. 6645 not associated). (D) Venn diagrams demonstrating the overlap
between regions bound by Smad2/3 and regions bound by both H3K4me1 and H3K27ac at stages 9 and 10.5. (E) DAVID analysis of genes associated with Smad2/3, H3K4me1
and H3K27ac bound regions (Nodal enhancers) at stage 9 (orange), stage 10.5 (dark green) and genes associated only with Smad2/3 bound regions at stage 9 (yellow) and
stage 10.5 (light green).
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Examination of the 178 genes within the “Regulation of
transcription” cluster reveals many important developmental
transcription factors, including eomes, smad1, foxA1, foxA2, tcf3,
sox17β.1, gata4, gata6, sox1, sox2, sox3, sox7, pax2, pax6, otx1, otx2,
pitx1, pitx2, meis2, dlx1, dlx2, dlx3, irx2, irx3, pou3f4, pou3f1, six2,
not1, not2, suz12, and twist1 (Supplemental Table S2). This is
surprising as it suggests that, by early blastula stage, many key
developmental loci already have H3K4me1 and H3K27ac marks,
though these regions may not initiate expression until much later
in development. Interestingly, most of these genes lack H3K4me3
at their promoters, suggesting that no transcription is occurring,
consistent with the fact that most of these genes are not known to
be expressed until gastrulation. We ﬁnd that only smad1, sox2 and
sox3 contain H3K4me3 marks near the TSS, suggesting that most
of these developmental loci contain the signature of an active
enhancer, but in the absence of transcription. Indeed, if we
examine published RNA-Seq and microarray datasets for these
transcripts, we ﬁnd most (18/31) increase by over 2 fold from stage
8 to stage 12 (Yanai et al., 2011; Tan et al., 2013), strongly
suggesting that while these developmental genes can be asso-
ciated with enhancer marks at stage 8, they are not actively
transcribed. Overall this suggests that, in Xenopus, the active
enhancer marks H3K4me1 and H3K27ac precede gene expression
by several hours and embryonic stages. This suggests that in
Xenopus, enhancer marks are established before active transcrip-
tion, in contrast to stem cells where enhancer marks are imme-
diately associated with active transcription (Creyghton et al., 2010;
Rada-Iglesias et al., 2011; Shlyueva et al., 2014).
Identiﬁcation of enhancers used by Nodal signaling in blastula and
gastrula
To identify speciﬁcally those enhancers used by Nodal in the
X. tropicalis embryo, we examined genomic regions occupied by
Smad2/3. Nodal signaling is necessary and sufﬁcient to establish
both mesoderm and endoderm, but outside of the few character-
ized Nodal enhancers or Activin Response Elements (AREs)
(Germain et al., 2000; Huang et al., 1995; Kimura et al., 1997;
Rebbert and Dawid, 1997; Ryan et al., 2000; Saijoh et al., 1999;
Shiratori et al., 2001; Watabe et al., 1995), it is unknown how and
where Smad2/3 regulates transcription to drive Nodal responses.
To this end, we performed ChIP-Seq (using an antibody that
recognizes both Smad2 and Smad3) to examine Smad2/3 occu-
pancy genome-wide at stage 8, 9 and 10.5. Although we were able
to detect Smad2/3 binding in embryos at stage 8, we note that our
Smad2 ChIP-Seq libraries for this stage were poor, with a high
number of duplicate reads relative to our other libraries, and that
we had to pool DNA from numerous ChIPs to generate enough
material. We consider it likely that the small amount of DNA
available in a stage 8 embryo, coupled with the small percentage
of DNA that is bound by Smad2, contributed to poor library quality.
Therefore, while we present our overall data for Smad2/3 binding
at stage 8 as a potential resource, we acknowledge that more
regions may be functionally bound by Smad2/3 at stage 8 than we
were able to detect. Our libraries at stage 9 and stage 10.5,
however, were very high quality, with high amounts of ChIP
DNA and a low percentage of duplicated reads (see the Experi-
mental procedures section).
Comparing stages, we ﬁnd a small number of Smad2/3 occu-
pied regions at stage 8 (207), which increases to 865 at stage 9 and
1024 at stage 10.5 (Fig. 3A). Smad2/3 occupied regions are not
associated with more than one developmental stage (Fig. 3B, left).
This is surprisingly distinct from what we observe with putative
enhancers, which when marked at stage 8 remain through stage
10.5 (Fig. 2D).
As Smad2/3 is known to drive cell fate speciﬁcation during
blastula and gastrula stages, we sought to identify the target genes
and their function. We identiﬁed 488 and 625 genes associated
with Smad2/3 occupancy at stage 9 and 10.5, respectively (Fig. 3A).
We found that only a few genes associated with a Smad2/3-bound
region at stage 9 remain associated at stage 10.5 (38/488) (Fig. 3B,
right). A similar pattern is found when comparing the data from
stage 8 (data not shown). Although the role of Nodal signaling in
cell fate speciﬁcation at blastula stages is well established, our
results suggest that Smad2/3 binding may be highly transient or
weak during blastula stages and – while certainly it drives the
expression of at least a handful of developmental genes – this
binding falls below our detection thresholds. Lowering the false
discovery cutoff did not signiﬁcantly improve our ability to detect
Smad2/3 occupancy at blastula stages. Smad2/3 is known to
shuttle dynamically between the nucleus and cytoplasm, and only
accumulates in the nucleus of Xenopus cells after the midblastula
transition (Saka et al., 2007; Schmierer and Hill, 2005). Therefore,
we consider it likely that by proﬁling Smad2/3 binding throughout
the whole embryo at blastula stages, we are unable to capture
transient events of Smad2/3 binding, which occur predominantly
in only the prospective dorsal mesendoderm.
We then asked whether a Smad2/3 occupied region is pre-
dictive of neighboring gene transcription. To this end, we com-
pared 3SEQ transcription levels from genes associated with a
Smad2/3 occupied region to those genes not associated with a
Smad2/3 occupied region. We found expression data for 293 and
404 genes at stages 9 and 10.5 respectively (see Fig. 3A) and
compared the mean expression level of these gene sets with genes
expressed at each stage but not occupied by Smad2/3 (6555 and
6645 genes, respectively). This analysis found a signiﬁcant increase
in transcription levels from genes associated with Smad2/3-
occupied regions (Fig. 3C), strongly implying that Smad2/3 func-
tions to drive transcription at these loci.
As Nodal signaling is known to drive many developmental
processes, we next examined the overall function of genes that
neighbor a Smad2/3 occupied region at each stage using DAVID. By
stage 9, we identify weak enrichment in “HMG DNA binding
process” (p¼0.002), which is the top clustering term, driven by
many sox and fox genes. By stage 10.5, DAVID analysis uncovers
“Transcription factor activity” (p¼21013) and many other
developmental processes, including Wnt signaling (1.02107),
homeobox (7.83107), pattern speciﬁcation (7.63108) and
embryonic morphogenesis (5.9104) (Fig. 3E, light green). The
genes represented in these categories include all the major known
downstream effectors of Nodal signaling, including xbra, eomes,
otx2, sox2, sox3, nodal, pitx1 and mix1, and many developmentally
important genes, including Wnt, Tgfβ and Fgf pathway members
(Supplemental Table S3). Overall, this captures the known role of
Smad2/3 in driving critical developmental decisions during gas-
trulation and provides a wealth of enhancer information for this
important transcriptional network.
Nodal enhancers are found predominantly during gastrula stage
We next sought to identify putative Nodal enhancers through-
out the genome during blastula and gastrula formation in
X. tropicalis. To this end, we deﬁned which of the Smad2/3
occupied regions were also marked by both H3K27ac and
H3K4me1. Surprisingly, at stage 9 only a small fraction of
Smad2/3 occupied regions also contain both H3K4me1 and
H3K27ac (37/865), but by stage 10.5, this has increased to 92%
(941/1024) (Fig. 3D). Thus, by the gastrula stage, nearly all regions
bound by Smad2/3 also contain both H3K4me1 and H3K27ac. To
simplify nomenclature we refer to these regions as putative Nodal
enhancers throughout the remaining text. Examples of 21 well-
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known Nodal target genes, showing screenshots of Smad2/3 and
enhancer mark occupancy, are provided in Supplemental Fig. 1.
We next examined the function of genes associated with putative
Nodal enhancers. At stage 10.5, DAVID analysis shows signiﬁcant
enrichment in transcription factor activity (p¼6.181013), Homeo-
box (p¼2.99106), Wnt signaling pathway (p¼9.0108),
embryonic morphogenesis (p¼5.8104), and pattern speciﬁcation
process (p¼7.3108) (Fig. 3E, dark green). However, no signiﬁcant
enrichment in biological processes – including developmental – was
identiﬁed at stage 9 (or at stage 8). Overall, this suggests that, at stage
10.5, Nodal enhancers are robust, but that at earlier stages Smad2/3
must be weakly or transiently bound.
We next validated the putative Nodal enhancers, by examining
whether the AREs previously identiﬁed in Xenopus laevis and
mouse were found within this dataset (Kimura et al., 1997; Ryan
et al., 2000; Saijoh et al., 1999; Shiratori et al., 2001; Watabe et al.,
1995). Initially, we identiﬁed the orthologous regions of the
X. tropicalis genome that correspond to the AREs in X. laevis and
in mouse. We then compared the positions of the AREs with our
putative Nodal enhancers at stage 10.5 (Fig. 4). X. laevis contains
well-characterized AREs in the gsc and eomes promoters, which
correspond perfectly to the positions of Smad2/3, H3K4me1 and
H3K27ac occupancy in X. tropicalis (Fig. 4A and B). There is also
extremely good evolutionary conservation of this region between
the two species, with 93.2% and 84.9% nucleotide identity between
X. tropicalis and X. laevis, respectively (Supplemental Fig. 2B and C).
For pitx2, lefty, and otx2, we relied on functionally characterized
AREs in the mouse. For these regions, we performed sequence
alignments between the known mouse ARE region and the
scaffold containing the X. tropicalis ortholog of each gene to
identify the corresponding sequence in the X. tropicalis genome.
We ﬁnd that for each gene, the orthologous sequence in
X. tropiclalis contains a predicted Nodal enhancer at the same
position as the mouse ARE, and that predicted FoxH1/Fast1 and
Smad2 sites are well conserved (Fig. 4C–E; Supplemental Fig. 2C–
E). As Smad2/3 binding occurs predominantly (92%) in the pre-
sence of both H3K4me1 and H3K27ac at stage 10.5, we examined
these genomic regions more closely for a broad distribution of
H3K27ac and H3K4me1 surrounding narrow Smad2/3 bound
regions. This distribution pattern has been associated with enhan-
cer elements in stem cells, mouse adult tissues and Drosophila
(Bonn et al., 2012; Creyghton et al., 2010; Rada-Iglesias et al., 2011;
Zentner et al., 2011). At stage 9 and 10.5 we observe this trend
clearly at many of the putative Nodal enhancers, including at the
well-characterized gsc, eomes pitx2, lefty and otx2 AREs (Fig. 4).
Overall we ﬁnd that all 5 known AREs, from both X. laevis and
mouse, are conserved in X. tropicalis. Importantly, these AREs were
identiﬁed as putative Nodal enhancers in this study. This serves to
validate the datasets and suggests we can effectively identify
functional enhancers.
Enhancers in blastula predict where Smad2/3 will bind during
gastrulation
We next examined whether putative enhancers preceded
Smad2/3 occupancy during embryonic development. While much
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Fig. 4. Putative Nodal enhancers correspond to known functional enhancers in X.
laevis and in mouse. (A) Genome browser shot of the gsc locus and its regulatory
regions on xentro2 scaffold 185. Scale is shown at top. The gsc gene model is shown
in purple. The ChIP-Seq read pile-up of Smad2/3 is shown in light green, with Nodal
enhancer regions shown as black bars. ChIP-Seq read pileups are shown in orange
for the putative enhancer histone marks H3K27ac (orange) and H3K4me1 (green),
and the entire putative enhancer regions of H3K4me1/H3K27ac overlap for stage
10.5, stage 9, and SB431542-treated are shown as black lines. Note that the putative
enhancer (H3K4me1/H3K27ac marked) regions are quite broad, while the region of
Smad2/3 binding is narrow. The region corresponding to the published activin
responsive element (ARE) for gsc in Xenopus laevis is shown in red, and the percent
identity is indicated for the alignment of the X. laevis enhancer and orthologous X.
tropicalis genomic coordinates. (B) Genome browser shot, putative enhancer
regions, and known X. laevis enhancer position for eomesodermin on scaffold 26.
ChIP-Seq data and X. laevis enhancer positions are marked as above. (C) Genome
browser shot, putative enhancer regions, and known mouse enhancer position for
pitx2 on scaffold 89. ChIP-Seq data and mouse enhancer positions are marked as
above. (D) Genome browser shot, putative enhancer regions, and known mouse
enhancer position for lefty on scaffold 719. (E) Genome browser shot, putative
enhancer regions, and known mouse enhancer position for otx2 on scaffold 68.
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progress has been made in identifying enhancers in many organ-
isms, how these enhancers are built over time to drive cell type
speciﬁc transcription is an open question. Therefore, we pulled out
the 865 regions bound by Smad2/3 at stage 9 and examined
whether these regions had previously been marked at stage 8 by
H3K4me3, H3K27ac, H3K4me1 or H3K27me3. For this purpose,
ﬁrst we extracted the tag densities for each mark at stage
8 surrounding the 5kb region bound by Smad2/3 at stage 9.
Next, we visualized the patterning of these marks using TreeView
(Saldanha, 2004). We represented these results as a heatmap
with each Smad2/3 occupied region as a point on the Y axis
(865) and the genomic coordinates surrounding each region on
the X axis (2500 bp on either side of Smad2/3 occupancy). We
observe very little correlation of any histone mark at stage 8
with regions occupied by Smad2/3 at stage 9 (Fig. 5A). To further
deﬁne the overlap between putative enhancers at stage 8 and
Smad2/3 at stage 9, we compared the occupancy data as a Venn
diagram (Fig. 5C, left). This again reveals that very few putative
enhancers at stage 8 are occupied by Smad2/3 at stage 9. Overall,
stage 8 putative enhancers do not predict Smad2/3 binding at
stage 9.
We next examined whether putative enhancers at blastula
predict eventual Smad2/3 occupancy at gastrulation. To this end,
we performed the same analysis as above, but compared histone
marks at stage 9 with Smad2/3 occupancy at stage 10.5. Again, tag
densities were represented as a heatmap with each Smad2/3
occupied region at stage 10.5 as a point on the Y axis (1024) and
the genomic coordinates surrounding each region on the X axis
(2500 bp on either side of Smad2/3 occupancy). We ﬁnd that
putative enhancer marks at stage 9 are present in regions that will
eventually be bound by Smad2/3. We also show this association
with Venn diagrams that depict the overlap between regions
marked by H3K4me1 and H3K27ac at stage 9 and those bound
by Smad2/3 at stage 10.5. This analysis shows that most Smad2/3
occupied regions at stage 10.5 contain a putative enhancer at stage
9 (650/1024, 63%; Fig. 5C, right). We next determined whether
these putative enhancers were marked even earlier at stage 8. A
Venn diagram comparing putative enhancers at stage 8 with
regions bound by Smad2/3 at stage 10.5 show that, surprisingly,
many putative enhancers used by Smad2/3 can be identiﬁed at
early blastula stages (141/1024, 14%; Fig. 5D, middle). Interestingly,
we ﬁnd these 141 regions are associated with many known Nodal
target genes, including xbra, lhx1, eomes, otx2, fgf8, sox2, sox3,
pitx1, pitx2, fzd1, not1, tsg101, bambi, bmp4, sprout, hhex, irx3, foxc2,
sox17b, gata3, gata4 and gata6, driving the enrichment for “Devel-
opmental protein” (8.2106) using DAVID. Overall this strongly
suggests that H3K27ac and H3K4me1 precede or prime particular
genomic regions at blastula stage prior to stable Smad2/3 associa-
tion during gastrulation.
Chromatin enhancer marks are independent of Nodal signaling
As our data suggests that Smad2/3 is recruited to enhancers that
were marked much earlier in development, we next examined
whether these marks are dependent upon Nodal signaling. To this
end, we ablated Nodal signaling by treating embryos with the drug
SB431542 at the 4 cell stage, which blocks the activity of Alk4/5
receptors and effectively inhibits all downstream Nodal signaling in
Xenopus embryos (Luxardi et al., 2010; Skirkanich et al., 2011).
Embryos treated with SB431542 fail to gastrulate as would be
expected for inhibition of Nodal signaling (see Fig. 6A). The Nodal
ablated embryos were harvested at stage 9, and examined by ChIP-
Seq using antibodies against both H3K4me1 and H3K27ac to identify
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Fig. 5. Deposition of enhancer marks precedes Smad2/3 binding. (A) Heat maps depicting binding intensities of H3K27me3, H3K4me3, H3K27ac, H3K4me1 at stage 8 (ﬁrst
four panels) at 5 kb region surrounding where Smad2/3 will bind at stage 9 (last panel). At stage 9, Smad2/3 occupies 865 regions, which is the Y axis. All regions are
centered around Smad2/3 binding, with 2.5 kb on either side (X axis). (B) Heat maps depicting binding intensities of H3K27me3, H3K4me3, H3K27ac, and H3K4me1 at stage
9 (ﬁrst four panels) at 5 kb region surrounding where Smad2/3 will bind at stage 10.5 (last panel). At stage 10.5, Smad2/3 occupies 1024 regions (Y axis). All regions are
centered around Smad2/3 occupancy, with 2.5 kb on either side (X axis). (C) Venn diagrams depicting how H3K4me1 and H3K27ac present at stage 8 and stage 9 predict
Smad2/3 association at stage 10.5. Left: comparison of stage 9 Smad2/3 bound regions with stage 8 putative enhancers. Middle: comparison of stage 10.5 Smad2/3 bound
regions with stage 8 putative enhancers. Right: comparison of stage 10.5 Smad2/3 bound regions with stage 9 putative enhancers.
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Fig. 6. Blocking Nodal signaling does not compromise H3K4me1/H3K27ac positioning. (A) Control embryos (left) or SB431542-treated embryos (right) showing the failure of
blastopore formation after inhibition of Nodal signaling at stage 10.5. (B) Left: bar graph representing the number of regions marked by H3K4me1, H3K27ac, or both marks
(putative enhancers) at stage 9, in either control embryos, SB431542-treated embryos, or both conditions (“Shared”); right: Venn diagram depicting the overlap of putative
enhancers in Control and SB431542-treated embryos at stage 9. Percentage of enhancers that are shared is shown in the center. (C) Left: bar graph representing the number
of putative enhancers at stage 9 that will acquire Smad2/3 binding at stage 10.5 (Nodal enhancers) in control embryos alone (“Control”) or both control and SB431542 treated
embryos (“Shared”). Nodal enhancer regions and associated genes are both shown; right: Venn diagram showing the overlap of Nodal enhancers (top) and associated genes
(bottom) in control and SB431542 treated embryos. The percentage of shared enhancers and genes is shown in the center of each diagram.
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putative enhancers. We identiﬁed 10,806 in the SB431542-treated
embryos and 9394 in the controls. Next, we compared the putative
enhancers between the two conditions and found that 5673 were
shared. Thus 60.4% (5673/9394) of putative enhancers are shared
between SB431542-treated and control embryos at stage 9 (Fig. 6B).
We next sought to determine how putative Nodal enhancers are
affected after SB431542-treatment. Previously, we identiﬁed 650
putative Nodal enhancers that were marked at stage 9 and then
occupied stably by Smad2/3 only at stage 10.5 (Fig. 5B and C). We then
examined whether these 650 marks were maintained after SB431542-
treatment. We ﬁnd that 503 of the 650 putative Nodal enhancers
maintain H3K4me1 and H3K27ac marks in the absence of Nodal
signaling (77.4%; see Fig. 6C).Whenwe associate these 503maintained
regions to their nearest neighboring genes, we ﬁnd that 99.1% of genes
retain a putative enhancer following Nodal inhibition (341/374 genes),
including gsc, xbra, eomes, otx2, fgf8, sox2, sox3 nodal1, vegT, sox17b,
gata4, and gata6. In Fig. 4 we highlight that putative enhancers at gsc,
eomes, pitx2, lefty and otx2 are maintained after SB431542 treatment
(black lines demarcating position of putative enhancers at stage 9 in
control and SB431542-treated embryos). Thus, putative enhancers for
critical developmental genes are marked normally in the absence of
Smad2/3, importantly suggesting that their establishment is indepen-
dent of zygotic Nodal signaling.
In this paper, we suggest that Nodal enhancers at important
developmental loci are established early during embryogenesis—at
least at blastula stages and possibly maternally. Further, we show that
these enhancers are not dependent upon Nodal signaling for their
establishment, strongly suggesting that a maternal protein is impor-
tant for the identiﬁcation of these regions and the subsequent
recruitment of histone variants to particular nucleosomes. FoxH1 is
known to function as a pioneer protein, which can recruit and
establish open chromatin conﬁgurations (Serandour et al., 2011;
Zaret and Carroll, 2011). As FoxH1 is also found maternally in the frog
oocyte and embryo and is a well-studied Smad2/3 co-factor (Kofron
et al., 2004), we propose that maternal FoxH1 may be responsible for
the establishment of eventual Nodal enhancers within the embryo. It
will be interesting to examine the role of FoxH1 as a potential
maternal pioneer factor in establishing developmental enhancers.
Overall, we suggest that Nodal enhancers are marked either mater-
nally or very soon after zygotic transcription and are used transiently
by Smad2/3 until gastrulationwhen they become stably bound. As it is
an open question how developmental enhancers are established
during embryogenesis in the vertebrate, this paper provides some of
the ﬁrst evidence showing that the chromatin is marked prior to
zygotic signals and that enhancer marks are established independent
of Nodal signaling.
Experimental procedures
X. tropicalis embryo isolation and culture
X. tropicalis embryos were generated by in vitro fertilization
according to published methods (Khokha et al., 2002). Embryos
were staged according to Nieuwkoop and Faber morphological
criteria. We made an extra effort to raise embryos at consistent
temperatures, so that embryos would reach a given developmental
stage at a similar time following fertilization. For Nodal inhibition,
embryos were cultured in SB431542 beginning at the 4 cell stage.
For each cohort of treated embryos, a few embryos were raised to
stage 10.5 and to stage 20, to conﬁrm loss of blastopore and of
dorsal anterior development.
RNA isolation and 3SEQ library preparation
Total RNA was isolated by collecting cohorts of 100 embryos
into Trizol (Invitrogen). 20 mg of starting total RNA was used for
each library. mRNA was prepared from total RNA by two rounds of
puriﬁcation using oligo-DT Dynabeads (Invitrogen, cat #610.06).
400 ng of poly-A selected RNA was used for library preparation.
Libraries for 3SEQ were prepared according to published methods
(Beck et al., 2010), using HPLC or PAGE puriﬁed primers, 3%
NuSieve GTG agarose for gel puriﬁcation, and an optimized ratio
of 0.75ul primer P7_oligodT (10 mM) per 200 ng polyA RNA for the
initial heat shearing step. Primers used were:
P7_OligoDT:
50 CAA GCA GAA GAC GGC ATA CGA GCT CTT CCG ATC TTT TTT
TTT TTT TTT TTT TTT TTT TVN 30
P5_LinkerA:
50 CCG AGA TCT ACA CTC TTT CCC TAC ACG ACG CTC TTC CGA
TCT 30
P5_LinkerB:
/5PHOS/GAT CGG AAG AGC GTC GTG TAG GGA AAG AGT 30 (50
Phos required for linker ligation)
PCR_F:
50 AAT GAT ACG GCG ACC ACC GAG ATC TAC ACT CTT TCC CTA
CAC GAC GCT CTT CCG ATC T 30
PCR_R:
50 CAA GCA GAA GAC GGC ATA CGA GCT CTT CTT CCG ATC 30
ChIP and ChIP-Seq library preparation
Chromatin immunoprecipitation from whole embryo lysates
was performed according to published methods (Blythe et al.,
2009; Wills et al., 2013), using pools of 250 embryos. DNA yields
from ChIP were pooled until 1ug of total DNA was generated; this
1ug of DNA was used to generate libraries for ChIP-Seq. Antibodies
used for ChIP were as follows:
Target Catalog number Company
H3K27ac ab4729 Abcam
H3K4me1 ab8895 Abcam
H3K4me3 39159 Active Motif
H3K27me3 39535 Active Motif
Smad2/3 (FL-425) sc-8332 Santa Cruz Biotechnology
ChIP-Seq data analysis
ChIP-Seq reads are mapped to xenTro2 genome using the
bowtie and bwa-sa tools (Langmead et al., 2009). GA II and HiSeq
sequencing platforms gave different yields of alignable reads, with
GA II generally yielding 10–20 aligned million reads and HiSeq 40–
100 million aligned reads. Both platforms gave sequencing cover-
age that was more than adequate to our analyses. Prior to analysis,
for each library and each biological replicate, all reads were ﬁltered
for quality, and duplicate and multimapped reads were discarded.
After discarding these reads, the remaining reads from multiple
biological replicate samples were pooled to provide greater
analytical power. We pooled reads from two biological replicates
for Smad2/3 Stage 9; H3K4me1 stage 8, 9, and 10; H3K4Me1 Stage
8, 9 and 10.5; H3K27ac stage 8, 9 and 10.5, and H3K4me3 stage 8,
9 and 10.5. These pooled reads were then aligned to the xentro2
(JGI4.1) X. tropicalis genome. For H3K4me3, we aligned 22,581,352;
10,828,491; and 10,227,842 reads to the genome at stages 8, 9
and 10.5, respectively (Fig. 1 data). For H3K27me3, we aligned
59,206,117; 24,305,339; and 37,175,470 reads to the genome at
stages 8, 9 and 10.5, respectively. For H3K27ac, we aligned
17,998,987; 76,511,738; and 50,444,132 reads to the genome at
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stages 8, 9 and 10.5, respectively (Fig. 2A data). For H3K4me1, we
aligned 26,879,020; 41,716,284; and 54,294,470 reads at stages 8,
9 and 10.5, respectively. For Smad2/3 we aligned 18,473,099;
27,673,586 and 7,611,088 reads to the genome at stages 8, 9, and
10.5, respectively (Fig. 3 data). Aligned ChIP-Seq ﬁles are used to
call peaks with the MACS2.08 software (Feng et al., 2012; Zhang
et al., 2008) at a stringent q value of 0.00001. For histone marks,
“—broad option” of the software is used. Input datasets are also
aligned to xenTro2 genome and are used as baseline for peak
calling. Called peaks are annotated using HOMER software to the
closest gene (Heinz et al., 2010). For promoter associated epige-
netic marks H3k4me3 and H3K27me3, peaks are assigned to genes
only if they are in the vicinity of a transcription start site, i.e., 1 kb
upstream or downstream of TSS. To visualize peaks using UCSC
Genome Browser, HOMER software (Heinz et al., 2010) was used to
generate bigWig and bedGraph ﬁles. To intersect peaks of different
marks, bedtools software (bedIntersect) was used (Quinlan and
Hall, 2010). All datasets are available in GEO: accession number
GSE56000.
3SEQ data analysis
Raw counts from 3SEQ datasets are calculated and annotated to
the closest genes using the Unipeak software (Foley and Sidow,
2013). DESeq software is used to normalize the raw counts data
and to ﬁnd the differentially expressed genes (Anders and Huber,
2010). In-house Perl scripts are used to intersect expression data
with gene lists derived from the ChIP-Seq data.
Clustering and gene ontology analysis
Tag density values around 2.5 kb up and downstream of called
peaks are generated using the HOMER software. Extracted tag
density values around peaks are visualized using the TreeView
software (Saldanha, 2004).
Gene ontology analysis was performed using the “Functional
Annotation Clustering” tool of DAVID software (Huang et al., 2009a,
2009b). Gene lists were submitted using the “Ofﬁcial_Gene_Symbol”
preset and restricted to X. tropicalis IDs. Only categories with
enrichment values greater than 1.3 (generally corresponding to p
values at or near 0.01) were considered signiﬁcant, according to the
software's author recommendations.
Acknowledgements
We thank Christine Reid for critical comments on the manu-
script, and members of the Baker lab for thoughtful and productive
discussion during this project. This work was supported by grants
from the National Institute of General Medical Sciences and the
National Institute of Child Health and Human Development (NIH
R01GM103787, NIH R01HD076839, and NIH R01GM095346). The
authors declare no competing interests.
Appendix A. Supporting information
Supplementary data associated with this article can be found in
the online version at http://dx.doi.org/10.1016/j.ydbio.2014.08.034.
References
Akkers, R.C., van Heeringen, S.J., Jacobi, U.G., Janssen-Megens, E.M., Francoijs, K.J.,
Stunnenberg, H.G., Veenstra, G.J., 2009. A hierarchy of H3K4me3 and
H3K27me3 acquisition in spatial gene regulation in Xenopus embryos. Dev.
Cell 17, 425–434.
Anders, S., Huber, W., 2010. Differential expression analysis for sequence count
data. Genome Biol. 11, R106.
Andersson, R., Gebhard, C., Miguel-Escalada, I., Hoof, I., Bornholdt, J., Boyd, M., Chen,
Y., Zhao, X., Schmidl, C., Suzuki, T., Ntini, E., Arner, E., Valen, E., Li, K.,
Schwarzﬁscher, L., Glatz, D., Raithel, J., Lilje, B., Rapin, N., Bagger, F.O., Jorgensen,
M., Andersen, P.R., Bertin, N., Rackham, O., Burroughs, A.M., Baillie, J.K., Ishizu,
Y., Shimizu, Y., Furuhata, E., Maeda, S., Negishi, Y., Mungall, C.J., Meehan, T.F.,
Lassmann, T., Itoh, M., Kawaji, H., Kondo, N., Kawai, J., Lennartsson, A., Daub,
C.O., Heutink, P., Hume, D.A., Jensen, T.H., Suzuki, H., Hayashizaki, Y., Muller, F.,
Forrest, A.R., Carninci, P., Rehli, M., Sandelin, A., 2014. An atlas of active
enhancers across human cell types and tissues. Nature 507, 455–461.
Beck, A.H., Weng, Z., Witten, D.M., Zhu, S., Foley, J.W., Lacroute, P., Smith, C.L., Tibshirani,
R., van de Rijn, M, Sidow, A., West, R.B., 2010. 30-End sequencing for expression
quantiﬁcation (3SEQ) from archival tumor samples. PLoS One 5, e8768.
Blythe, S.A., Cha, S.W., Tadjuidje, E., Heasman, J., Klein, P.S., 2010. beta-Catenin
primes organizer gene expression by recruiting a histone H3 arginine 8 methyl-
transferase, Prmt2. Dev. Cell 19, 220–231.
Blythe, S.A., Reid, C.D., Kessler, D.S., Klein, P.S., 2009. Chromatin immunoprecipita-
tion in early Xenopus laevis embryos. Dev. Dyn. 238, 1422–1432.
Bonn, S., Zinzen, R.P., Girardot, C., Gustafson, E.H., Perez-Gonzalez, A., Delhomme,
N., Ghavi-Helm, Y., Wilczynski, B., Riddell, A., Furlong, E.E., 2012. Tissue-speciﬁc
analysis of chromatin state identiﬁes temporal signatures of enhancer activity
during embryonic development. Nat. Genet. 44, 148–156.
Calo, E., Wysocka, J., 2013. Modiﬁcation of enhancer chromatin: what, how, and
why? Mol. Cell 49, 825–837.
Chen, X., Rubock, M.J., Whitman, M., 1996. A transcriptional partner for MAD
proteins in TGF-beta signalling. Nature 383, 691–696.
Chen, X., Weisberg, E., Fridmacher, V., Watanabe, M., Naco, G., Whitman, M., 1997.
Smad4 and FAST-1 in the assembly of activin-responsive factor. Nature 389,
85–89.
Creyghton, M.P., Cheng, A.W., Welstead, G.G., Kooistra, T., Carey, B.W., Steine, E.J.,
Hanna, J., Lodato, M.A., Frampton, G.M., Sharp, P.A., Boyer, L.A., Young, R.A.,
Jaenisch, R., 2010. Histone H3K27ac separates active from poised enhancers and
predicts developmental state. Proc. Natl. Acad. Sci. U.S.A. 107, 21931–21936.
Feng, J., Liu, T., Qin, B., Zhang, Y., Liu, X.S., 2012. Identifying ChIP-seq enrichment
using MACS. Nat. Protoc. 7, 1728–1740.
Foley, J.W., Sidow, A., 2013. Transcription-factor occupancy at HOT regions
quantitatively predicts RNA polymerase recruitment in ﬁve human cell lines.
BMC Genomics 14, 720.
Germain, S., Howell, M., Esslemont, G.M., Hill, C.S., 2000. Homeodomain and
winged-helix transcription factors recruit activated Smads to distinct promoter
elements via a common Smad interaction motif. Genes Dev. 14, 435–451.
Heintzman, N.D., Hon, G.C., Hawkins, R.D., Kheradpour, P., Stark, A., Harp, L.F., Ye, Z.,
Lee, L.K., Stuart, R.K., Ching, C.W., Ching, K.A., Antosiewicz-Bourget, J.E., Liu, H.,
Zhang, X., Green, R.D., Lobanenkov, V.V., Stewart, R., Thomson, J.A., Crawford,
G.E., Kellis, M., Ren, B., 2009. Histone modiﬁcations at human enhancers reﬂect
global cell-type-speciﬁc gene expression. Nature 459, 108–112.
Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y.C., Laslo, P., Cheng, J.X., Murre, C.,
Singh, H., Glass, C.K., 2010. Simple combinations of lineage-determining
transcription factors prime cis-regulatory elements required for macrophage
and B cell identities. Mol. Cell 38, 576–589.
Huang, D.W., Sherman, B.T., Lempicki, R.A., 2009a. Bioinformatics enrichment tools:
paths toward the comprehensive functional analysis of large gene lists. Nucleic
Acids Res. 37, 1–13.
Huang, D.W., Sherman, B.T., Lempicki, R.A., 2009b. Systematic and integrative analysis
of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44–57.
Huang, H.C., Murtaugh, L.C., Vize, P.D., Whitman, M., 1995. Identiﬁcation of a
potential regulator of early transcriptional responses to mesoderm inducers in
the frog embryo. EMBO J. 14, 5965–5973.
Khokha, M.K., Chung, C., Bustamante, E.L., Gaw, L.W., Trott, K.A., Yeh, J., Lim, N., Lin,
J.C., Taverner, N., Amaya, E., Papalopulu, N., Smith, J.C., Zorn, A.M., Harland, R.M.,
Grammer, T.C., 2002. Techniques and probes for the study of Xenopus tropicalis
development. Dev. Dyn. 225, 499–510.
Kim, S.W., Yoon, S.J., Chuong, E., Oyolu, C., Wills, A.E., Gupta, R., Baker, J., 2011.
Chromatin and transcriptional signatures for Nodal signaling during endoderm
formation in hESCs. Dev. Biol. 357, 492–504.
Kimura, C., Takeda, N., Suzuki, M., Oshimura, M., Aizawa, S., Matsuo, I., 1997. Cis-
acting elements conserved between mouse and pufferﬁsh Otx2 genes govern
the expression in mesencephalic neural crest cells. Development 124,
3929–3941.
Kofron, M., Puck, H., Standley, H., Wylie, C., Old, R., Whitman, M., Heasman, J., 2004.
New roles for FoxH1 in patterning the early embryo. Development 131,
5065–5078.
Langmead, B., Trapnell, C., Pop, M., Salzberg, S.L., 2009. Ultrafast and memory-
efﬁcient alignment of short DNA sequences to the human genome. Genome
Biol. 10, R25.
Lindeman, L.C., Andersen, I.S., Reiner, A.H., Li, N., Aanes, H., Ostrup, O., Winata, C.,
Mathavan, S., Muller, F., Alestrom, P., Collas, P., 2011. Prepatterning of develop-
mental gene expression by modiﬁed histones before zygotic genome activation.
Dev. Cell 21, 993–1004.
Luxardi, G., Marchal, L., Thome, V., Kodjabachian, L., 2010. Distinct Xenopus Nodal
ligands sequentially induce mesendoderm and control gastrulation movements
in parallel to the Wnt/PCP pathway. Development 137, 417–426.
Negre, N., Brown, C.D., Ma, L., Bristow, C.A., Miller, S.W., Wagner, U., Kheradpour, P.,
Eaton, M.L., Loriaux, P., Sealfon, R., Li, Z., Ishii, H., Spokony, R.F., Chen, J., Hwang,
L., Cheng, C., Auburn, R.P., Davis, M.B., Domanus, M., Shah, P.K., Morrison, C.A.,
R. Gupta et al. / Developmental Biology 395 (2014) 38–4948
Zieba, X.S., Suchy, S., Senderowicz, L., Victorsen, A., Bild, N.A., Grundstad, A.J.,
Hanley, D., MacAlpine, D.M., Mannervik, M., Venken, K., Bellen, H., White, R.,
Gerstein, M., Russell, S., Grossman, R.L., Ren, B., Posakony, J.W., Kellis, M., White,
K.P., 2011. A cis-regulatory map of the Drosophila genome. Nature 471, 527–531.
Nieuwkoop, P.D., Faber, J., 1967. Normal Table of Xenopus laevis. North Holland
Publishing Company, Amsterdam.
Quinlan, A.R., Hall, I.M., 2010. BEDTools: a ﬂexible suite of utilities for comparing
genomic features. Bioinformatics 26, 841–842.
Rada-Iglesias, A., Bajpai, R., Swigut, T., Brugmann, S.A., Flynn, R.A., Wysocka, J., 2011.
A unique chromatin signature uncovers early developmental enhancers in
humans. Nature 470, 279–283.
Rada-Iglesias, A., Wysocka, J., 2011. Epigenomics of human embryonic stem cells
and induced pluripotent stem cells: insights into pluripotency and implications
for disease. Genome Med. 3, 36.
Rebbert, M.L., Dawid, I.B., 1997. Transcriptional regulation of the Xlim-1 gene by
activin is mediated by an element in intron I. Proc. Natl. Acad. Sci. U.S.A. 94,
9717–9722.
Ryan, K., Garrett, N., Bourillot, P., Stennard, F., Gurdon, J.B., 2000. The Xenopus
eomesodermin promoter and its concentration-dependent response to activin.
Mech. Dev. 94, 133–146.
Saijoh, Y., Adachi, H., Mochida, K., Ohishi, S., Hirao, A., Hamada, H., 1999. Distinct
transcriptional regulatory mechanisms underlie left-right asymmetric expres-
sion of lefty-1 and lefty-2. Genes Dev. 13, 259–269.
Saka, Y., Hagemann, A.I., Piepenburg, O., Smith, J.C., 2007. Nuclear accumulation of
Smad complexes occurs only after the midblastula transition in Xenopus.
Development 134, 4209–4218.
Saldanha, A.J., 2004. Java Treeview—extensible visualization of microarray data.
Bioinformatics 20, 3246–3248.
Schmierer, B., Hill, C.S., 2005. Kinetic analysis of Smad nucleocytoplasmic shuttling
reveals a mechanism for transforming growth factor beta-dependent nuclear
accumulation of Smads. Mol. Cell. Biol. 25, 9845–9858.
Serandour, A.A., Avner, S., Percevault, F., Demay, F., Bizot, M., Lucchetti-Miganeh, C.,
Barloy-Hubler, F., Brown, M., Lupien, M., Metivier, R., Salbert, G., Eeckhoute, J.,
2011. Epigenetic switch involved in activation of pioneer factor FOXA1-
dependent enhancers. Genome Res. 21, 555–565.
Shiratori, H., Sakuma, R., Watanabe, M., Hashiguchi, H., Mochida, K., Sakai, Y.,
Nishino, J., Saijoh, Y., Whitman, M., Hamada, H., 2001. Two-step regulation of
left-right asymmetric expression of Pitx2: initiation by nodal signaling and
maintenance by Nkx2. Mol. Cell 7, 137–149.
Shlyueva, D., Stampfel, G., Stark, A., 2014. Transcriptional enhancers: from proper-
ties to genome-wide predictions. Nat. Rev. Genet. 15, 272–286.
Skirkanich, J., Luxardi, G., Yang, J., Kodjabachian, L., Klein, P.S., 2011. An essential
role for transcription before the MBT in Xenopus laevis. Dev. Biol. 357, 478–491.
Tan, M.H., Au, K.F., Yablonovitch, A.L., Wills, A.E., Chuang, J., Baker, J.C., Wong, W.H.,
Li, J.B., 2013. RNA sequencing reveals a diverse and dynamic repertoire of the
Xenopus tropicalis transcriptome over development. Genome Res. 23, 201–216.
van Heeringen, S.J., Akkers, R.C., van Kruijsbergen, I., Arif, M.A., Hanssen, L.L., Shariﬁ,
N., Veenstra, G.J., 2013. Principles of nucleation of H3K27 methylation during
embryonic development. Genome Res..
Watabe, T., Kim, S., Candia, A., Rothbacher, U., Hashimoto, C., Inoue, K., Cho, K.W.,
1995. Molecular mechanisms of Spemann's organizer formation: conserved
growth factor synergy between Xenopus and mouse. Genes Dev. 9, 3038–3050.
Watanabe, M., Whitman, M., 1999. FAST-1 is a key maternal effector of mesoderm
inducers in the early Xenopus embryo. Development 126, 5621–5634.
Wills, A.E., Gupta, R., Chuong, E., Baker, J.C., 2013. Chromatin immunoprecipitation
and deep sequencing in Xenopus tropicalis and Xenopus laevis. Methods.
Yanai, I., Peshkin, L., Jorgensen, P., Kirschner, M.W., 2011. Mapping gene expression
in two Xenopus species: evolutionary constraints and developmental ﬂexibility.
Dev. Cell 20, 483–496.
Zaret, K.S., Carroll, J.S., 2011. Pioneer transcription factors: establishing competence
for gene expression. Genes Dev. 25, 2227–2241.
Zentner, G.E., Tesar, P.J., Scacheri, P.C., 2011. Epigenetic signatures distinguish
multiple classes of enhancers with distinct cellular functions. Genome Res.
21, 1273–1283.
Zhang, Y., Liu, T., Meyer, C.A., Eeckhoute, J., Johnson, D.S., Bernstein, B.E., Nusbaum,
C., Myers, R.M., Brown, M., Li, W., Liu, X.S., 2008. Model-based analysis of ChIP-
Seq (MACS). Genome Biol. 9, R137.
R. Gupta et al. / Developmental Biology 395 (2014) 38–49 49
